News

Coca-Cola, Facebook execs talk social media at NACDS Marketplace

BY Michael Johnsen

DENVER — Executives from Coca-Cola and Facebook on Monday morning shared social media best practices and strategies here at NACDS Marketplace 2012.

Social media is about engaging the end-consumer in an interactive dialogue, more than it is about accumulating “likes.”

“The most valuable channel to engage the consumer is the news feed,” suggested Mike Haines, director of market solutions for Facebook. “Don’t think about your page as a destination … but as a launching point for the news feed.” Facebook is the power of word-of-mouth unleashed, Haines added.

That’s in part because social media is about telling a brand story. “Stories are the most powerful ways to share ideas,” noted JD Doughney, senior social marketing manager for Coca-Cola. “They’re also the most sticky way to retain information.” Social media also is ubiquitous.

“How far is the average person in the United States away from [his or her] smartphone? It’s literally 3 ft.,” commented John Carroll, VP drug and value channel for Coca-Cola. According to Carroll, 1-in-5 shopping trips start on Google, as many as 40% of 18 to 34 year olds use handheld devices to search for coupons, and half of all consumers use social media to learn about deals.

However, social media also should be a contributory revenue stream, not another cost center. For example, Haines noted, Walmart is using Facebook to help augment its relationship with shoppers at the community level. Shoppers who “like” Walmart’s page are asked to identify with a particular store, Haines said, which enables Walmart to target ad campaigns at the actual store level.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Federal court rules against Mylan in MS drug case

BY Alaric DeArment

PITTSBURGH — A federal court has ruled against Mylan in a case filed by Teva Pharmaceutical Industries over a drug to treat multiple sclerosis.

The U.S. District Court for the Southern District of New York ruled Monday that Mylan’s proposed generic version of the drug Copaxone (glatiramer acetate) infringed Teva’s patents.

Mylan responded that it was "disappointed" by the decision and would appeal once it had the opportunity to review it in full.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Upsher-Smith launches Provella for women

BY Allison Cerra

MAPLE GROVE, Minn. — Upsher-Smith Labs has launched a probiotic dietary supplement specifically designed for women to promote digestive, feminine and immune health, the company said.

Provella contains a proprietary blend of six bacteria strains that include: Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri and Bifidobacterium bifidum. Designed to be taken once-daily by mouth, the supplement is available without a prescription behind the pharmacy counter at retail pharmacies nationwide.

"With the introduction of Provella, we’re pleased to offer women a probiotic supplement that contains a unique blend of beneficial bacteria to promote digestive, feminine and immune health," said Gregory Gilmet, senior medical director of medical affairs at Upsher-Smith. "As our portfolio of women’s products continues to expand, so does our commitment to helping women achieve and maintain a healthy lifestyle."


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?